Role of cephalosporins in the era ofClostridium difficileinfection

Risk factors for Clostridium difficile infection in hospitalized patients with community-acquired pneumonia

(2016) James D. Chalmers et al.   JOURNAL OF INFECTION

Ecological Effect of Ceftaroline-Avibactam on the Normal Human Intestinal Microbiota

(2015) Mamun-Ur Rashid et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Current Trends in the Epidemiology and Outcomes of Clostridium difficile Infection

(2015) Charlesnika T. Evans et al.   CLINICAL INFECTIOUS DISEASES

Ecological effect of ceftazidime/avibactam on the normal human intestinal microbiota

(2015) Mamun-Ur Rashid et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Burden of Clostridium difficile Infection in the United States

(2015) Fernanda C. Lessa et al.   NEW ENGLAND JOURNAL OF MEDICINE

Clostridium difficile Infection

(2015) Daniel A. Leffler et al.   NEW ENGLAND JOURNAL OF MEDICINE

Antibiotic susceptibility of Clostridium difficile is similar worldwide over two decades despite widespread use of broad-spectrum antibiotics: an analysis done at the University Hospital of Zurich

(2014) Andrea C Büchler et al.   BMC INFECTIOUS DISEASES

Underdiagnosis of Clostridium difficile across Europe: the European, multicentre, prospective, biannual, point-prevalence study of Clostridium difficile infection in hospitalised patients with diarrhoea (EUCLID)

(2014) Kerrie A Davies et al.   LANCET INFECTIOUS DISEASES

Cycling Empirical Antibiotic Therapy in Hospitals: Meta-Analysis and Models

(2014) Pia Abel zur Wiesch et al.   PLoS Pathogens

Meta-Analysis of Antibiotics and the Risk of Community-Associated Clostridium difficile Infection

(2013) Kevin A. Brown et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Ceftazidime-Avibactam: a Novel Cephalosporin/β-lactamase Inhibitor Combination

(2013) George G. Zhanel et al.   DRUGS

Evaluation of antimicrobial activity of ceftaroline against Clostridium difficile and propensity to induce C. difficile infection in an in vitro human gut model

(2013) S. D. Baines et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Community-associated Clostridium difficile infection and antibiotics: a meta-analysis

(2013) Abhishek Deshpande et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Antibiotics and hospital-acquired Clostridium difficile infection: update of systematic review and meta-analysis

(2013) Claudia Slimings et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Intestinal Dysbiosis and Depletion of Butyrogenic Bacteria in Clostridium difficile Infection and Nosocomial Diarrhea

(2013) V. C. Antharam et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Differences in outcome according to Clostridium difficile testing method: a prospective multicentre diagnostic validation study of C difficile infection

(2013) Timothy D Planche et al.   LANCET INFECTIOUS DISEASES

Diverse Sources of C. difficile Infection Identified on Whole-Genome Sequencing

(2013) David W. Eyre et al.   NEW ENGLAND JOURNAL OF MEDICINE

In Vivo Absorption and Disposition of Cefadroxil After Escalating Oral Doses in Wild-Type and PepT1 Knockout Mice

(2013) Maria M. Posada et al.   PHARMACEUTICAL RESEARCH

Can we identify patients at high risk of recurrent Clostridium difficile infection?

(2012) C.P. Kelly   CLINICAL MICROBIOLOGY AND INFECTION

Anti-anaerobic activity of a new β-lactamase inhibitor NXL104 in combination with β-lactams and metronidazole

(2012) L.J. Dubreuil et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Clinical and economic burden of Clostridium difficile infection in Europe: a systematic review of healthcare-facility-acquired infection

(2012) P.N. Wiegand et al.   JOURNAL OF HOSPITAL INFECTION

Effect of Ceftobiprole Treatment on Growth of and Toxin Production by Clostridium difficile in Cecal Contents of Mice

(2011) Michelle M. Nerandzic et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

In VitroActivity of Ceftazidime-NXL104 against 396 Strains of β-Lactamase-Producing Anaerobes

(2011) Diane M. Citron et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Cumulative Antibiotic Exposures Over Time and the Risk of Clostridium difficile Infection

(2011) V. Stevens et al.   CLINICAL INFECTIOUS DISEASES

In VitroActivity of Ceftaroline against a Broad Spectrum of Recent Clinical Anaerobic Isolates

(2010) David R. Snydman et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Effect of Ceftaroline on Normal Human Intestinal Microflora

(2010) G. Panagiotidis et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

The Changing Epidemiology of Clostridium difficile Infections

(2010) J. Freeman et al.   CLINICAL MICROBIOLOGY REVIEWS

Clostridium difficile infection in an endemic setting in the Netherlands

(2010) M. P. M. Hensgens et al.   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

Effect of ceftobiprole on the normal human intestinal microflora

(2010) Tobias Bäckström et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Impact of different empirical antibiotic treatment regimens for community-acquired pneumonia on the emergence of Clostridium difficile

(2010) A. H. W. Bruns et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

The growing incidence and severity ofClostridium difficileinfection in inpatient and outpatient settings

(2010) Sahil Khanna et al.   Expert Review of Gastroenterology & Hepatology

In vitro susceptibility to 17 antimicrobials of clinical Clostridium difficile isolates collected in 1993–2007 in Sweden

(2009) T. Norén et al.   CLINICAL MICROBIOLOGY AND INFECTION

Pharmacokinetics and Pharmacodynamics of Ceftobiprole, an Anti-MRSA Cephalosporin with Broad-Spectrum Activity

(2009) Bindu Murthy et al.   CLINICAL PHARMACOKINETICS

Pharmacokinetics and Pharmacodynamics of Antibacterial Agents

(2009) Matthew E. Levison et al.   INFECTIOUS DISEASE CLINICS OF NORTH AMERICA

Clinical Recognition and Diagnosis ofClostridium difficileInfection

(2008) John G. Bartlett et al.   CLINICAL INFECTIOUS DISEASES

A case-control study of community-associated Clostridium difficile infection

(2008) M. H. Wilcox et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Clostridium difficile— More Difficult Than Ever

(2008) Ciarán P. Kelly et al.   NEW ENGLAND JOURNAL OF MEDICINE